BSH 2017 | Prospect of new therapies for AML

Mhairi Copland

Mhairi Copland, PhD, MB, ChB, MRCP, FRCPath from the University of Glasgow, Glasgow, UK, gives an overview of the session on targeted therapy and immunotherapy for acute myeloid leukemia (AML) at the 2017 British Society for Haematology (BSH) Annual Scientific Meeting in Brighton, UK. Prof. Copland discusses clinical trials in the UK and the prospect of new therapies for AML.

Share this video